Status:
UNKNOWN
BP Variability on the Outcomes of Hemodialysis Vascular Access
Lead Sponsor:
National Taiwan University Hospital Hsin-Chu Branch
Conditions:
Hemodialysis Access Failure
Blood Pressure
Eligibility:
All Genders
18+ years
Brief Summary
Hemodialysis vascular access dysfunction continues to be a major source of morbidity and mortality in patients with ESRD. Thrombosis is the most common cause of secondary vascular access failure Altho...
Detailed Description
Hemodialysis vascular access dysfunction continues to be a major source of morbidity and mortality in patients with ESRD1. After the publication of the dialysis outcome quality initiative guidelines, ...
Eligibility Criteria
Inclusion
- age from 20-99 years old, undergoing regular hemodialysis for at least six months.
Exclusion
- (1) patients received regular dialysis less than 6 months
- (2) patients with clinical evidence of acute or chronic inflammation, decompensated heart failure, recent myocardial infarction, or unstable angina in recent 3 months
Key Trial Info
Start Date :
January 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
1300 Patients enrolled
Trial Details
Trial ID
NCT04692636
Start Date
January 1 2018
End Date
December 31 2022
Last Update
January 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital Hsinchu Branch
Hsinchu, Taiwan